MicroRNA‑634 functions as a tumor suppressor in pancreatic cancer via directly targeting heat shock‑related 70‑kDa protein 2

Chen,Duanrui; Wu,Xinglong; Zhao,Jianwen; Zhao,Xiangwen

doi:10.3892/etm.2019.7433

MicroRNA‑634 functions as a tumor suppressor in pancreatic cancer via directly targeting heat shock‑related 70‑kDa protein 2

Authors:
- Duanrui Chen
- Xinglong Wu
- Jianwen Zhao
- Xiangwen Zhao
View Affiliations

Affiliations: Oncology Department, Lanling County Hospital, Linyi, Shandong 277700, P.R. China, Laboratory of Scientific Research Center, Lanling County Hospital, Linyi, Shandong 277700, P.R. China, Cardiology Department, Lanling County Hospital, Linyi, Shandong 277700, P.R. China
Published online on: March 22, 2019 https://doi.org/10.3892/etm.2019.7433
Pages: 3949-3956
Copyright: © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Pancreatic cancer (PC) is one of the most malignant types of human cancer and has an extremely poor prognosis. MicroRNAs (miRs) reportedly serve a critical role in pancreatic ductal adenocarcinoma (PDAC) progression. Understanding the expression patterns and functions of miRs may provide strategies for the diagnosis and treatment of patients with PC. In particular, miR‑634 is attracting interest due to its critical role in regulating the biology of some types of cancer. However, the expression patterns, biological function and molecular mechanism of miR‑634 in PC remain unknown. In the present study, miR‑634 expression levels in PC tissues and cell lines were significantly downregulated. Notably, the ectopic overexpression of miR‑634 in PC cells inhibited tumor progression, whereas miR‑634 silencing reversed these effects. Furthermore, reverse transcription‑quantitative polymerase chain reaction, western blot analysis and the dual‑luciferase assay revealed that miR‑634 regulated heat shock‑related 70 kDa protein 2 (HSPA2) by directly binding to its 3'‑untranslated region. In clinical samples of PC, miR‑634 was inversely correlated with HSPA2, which was upregulated in PC. In the rescue experiment, HSPA2 overexpression partially abrogated the effects of miR‑634 mimicry on biological function. In conclusion, miR‑634 functioned as a tumor suppressor in regulating PC progression by targeting HSPA2 and may therefore be a novel potential therapeutic target for PC.

View Figures

View References

1	Siegel RL, Miller KD and Jemal A: Cancer statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
2	Li D, Xie K, Wolff R and Abbruzzese JL: Pancreatic cancer. Lancet. 363:1049–1057. 2004. View Article : Google Scholar : PubMed/NCBI
3	Oettle H, Post S, Neuhaus P, Gellert K, Langrehr J, Ridwelski K, Schramm H, Fahlke J, Zuelke C, Burkart C, et al: Adjuvant chemotherapy with gemcitabine vs. observation in patients undergoing curative-intent resection of pancreatic cancer: A randomized controlled trial. JAMA. 297:267–277. 2007. View Article : Google Scholar : PubMed/NCBI
4	Diab M, Muqbil I, Mohammad RM, Azmi AS and Philip PA: The role of microRNAs in the diagnosis and treatment of pancreatic adenocarcinoma. J Clin Med. 5:E592016. View Article : Google Scholar : PubMed/NCBI
5	Yonemori K, Kurahara H, Maemura K and Natsugoe S: MicroRNA in pancreatic cancer. J Hum Genet. 62:33–40. 2017. View Article : Google Scholar : PubMed/NCBI
6	Calin GA and Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
7	Tan Z, Zhao J and Jiang Y: MiR-634 sensitizes glioma cells to temozolomide by targeting CYR61 through Raf-ERK signaling pathway. Cancer Med. 7:913–921. 2018. View Article : Google Scholar : PubMed/NCBI
8	Guo J, Zhang CD, An JX, Xiao YY, Shao S, Zhou NM and Dai DQ: Expression of miR-634 in gastric carcinoma and its effects on proliferation, migration, and invasion of gastric cancer cells. Cancer Med. 7:776–787. 2018. View Article : Google Scholar : PubMed/NCBI
9	Zhang CZ, Cao Y, Fu J, Yun JP and Zhang MF: miR-634 exhibits anti-tumor activities toward hepatocellular carcinoma via Rab1A and DHX33. Mol Oncol. 10:1532–1541. 2016. View Article : Google Scholar : PubMed/NCBI
10	van Jaarsveld MT, van Kuijk PF, Boersma AW, Helleman J, van IJcken WF, Mathijssen RH, Pothof J, Berns EM, Verweij J and Wiemer EA: miR-634 restores drug sensitivity in resistant ovarian cancer cells by targeting the Ras-MAPK pathway. Mol Cancer. 14:1962015. View Article : Google Scholar : PubMed/NCBI
11	Cong J, Liu R, Wang X, Jiang H and Zhang Y: MiR-634 decreases cell proliferation and induces apoptosis by targeting mTOR signaling pathway in cervical cancer cells. Artif Cells Nanomed Biotechnol. 44:1694–1701. 2016. View Article : Google Scholar : PubMed/NCBI
12	Peng X, Cao P, He D, Han S, Zhou J, Tan G, Li W, Yu F, Yu J, Li Z and Cao K: miR-634 sensitizes nasopharyngeal carcinoma cells to paclitaxel and inhibits cell growth both in vitro and in vivo. Int J Clin Exp Pathol. 7:6784–6791. 2014.PubMed/NCBI
13	Chun YS, Pawlik TM and Vauthey JN: 8th edition of the AJCC cancer staging manual: Pancreas and hepatobiliary cancers. Ann Surg Oncol. 25:845–847. 2018. View Article : Google Scholar : PubMed/NCBI
14	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
15	Zhai LL, Xie Q, Zhou CH, Huang DW, Tang ZG and Ju TF: Overexpressed HSPA2 correlates with tumor angiogenesis and unfavorable prognosis in pancreatic carcinoma. Pancreatology. 17:457–463. 2017. View Article : Google Scholar : PubMed/NCBI
16	Zhang H, Gao H, Liu C, Kong Y, Wang C and Zhang H: Expression and clinical significance of HSPA2 in pancreatic ductal adenocarcinoma. Diagn Pathol. 10:132015. View Article : Google Scholar : PubMed/NCBI
17	Dix DJ, Allen JW, Collins BW, Poorman-Allen P, Mori C, Blizard DR, Brown PR, Goulding EH, Strong BD and Eddy EM: HSP70-2 is required for desynapsis of synaptonemal complexes during meiotic prophase in juvenile and adult mouse spermatocytes. Development. 124:4595–4603. 1997.PubMed/NCBI
18	Scieglinska D and Krawczyk Z: Expression, function, and regulation of the testis-enriched heat shock HSPA2 gene in rodents and humans. Cell Stress Chaperones. 20:221–235. 2015. View Article : Google Scholar : PubMed/NCBI
19	Fu Y, Zhao H, Li XS, Kang HR, Ma JX, Yao FF and Du N: Expression of HSPA2 in human hepatocellular carcinoma and its clinical significance. Tumour Biol. 35:11283–11287. 2014. View Article : Google Scholar : PubMed/NCBI
20	Zhang H, Chen W, Duan CJ and Zhang CF: Overexpression of HSPA2 is correlated with poor prognosis in esophageal squamous cell carcinoma. World J Surg Oncol. 11:1412013. View Article : Google Scholar : PubMed/NCBI
21	Scieglinska D, Gogler-Piglowska A, Butkiewicz D, Chekan M, Malusecka E, Harasim J, Habryka A and Krawczyk Z: HSPA2 is expressed in human tumors and correlates with clinical features in non-small cell lung carcinoma patients. Anticancer Res. 34:2833–2840. 2014.PubMed/NCBI
22	Garg M, Kanojia D, Saini S, Suri S, Gupta A, Surolia A and Suri A: Germ cell-specific heat shock protein 70-2 is expressed in cervical carcinoma and is involved in the growth, migration, and invasion of cervical cells. Cancer. 116:3785–3796. 2010. View Article : Google Scholar : PubMed/NCBI